Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,168,133
+$458,638 QoQ
Shares Held
131,567
+36.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#779
of 2,820 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GQG Partners LLC holds $855,412,874 across 8 Drug Manufacturers - General names. PFE ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,921,614 | $483,554,946 | |
| 2 | NVS |
Novartis AG
|
2,151,131 | $337,125,250 | |
| 3 | AZN |
Astrazeneca PLC
|
45,569 | $8,640,793 | |
| 4 | MRK |
Merck & Co., Inc.
|
53,092 | $6,822,322 | |
| 5 | JNJ |
Johnson & Johnson
|
25,158 | $6,389,377 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
96,264 | $5,546,731 | |
| 7 | SNY |
Sanofi
|
97,640 | $4,165,322 | |
| 8 | PFE |
Pfizer Inc
This page
|
131,567 | $3,168,133 |
All Filings in PFE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,168,133 | 131,567 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,709,495 | 96,492 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,402,401 | 96,482 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,488,274 | 97,656 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||